Lab
Sutter Bay Medical Foundation
Sutter Bay Medical Foundation was paid $19.65M by Medicaid between Jan 2018 and Dec 2024, across 309 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoSUTTER BAY MEDICAL FOUNDATION
PALO ALTO, CA 94301
PALO ALTO, CA 94301
33aNPI1013950807assigned 06/13/2006
33bProvider typeClinical Medical Laboratory
28Total paid$19.65M
24GClaims838,751
24DCodes billed309
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#46 of 561
Median peer was paid$222K
This provider vs. median89×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LOPES, KRISTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 119,813 | $2.89M | |
| 2019 | 110,638 | $2.67M | |
| 2020 | 99,656 | $2.20M | |
| 2021 | 139,679 | $3.34M | |
| 2022 | 130,467 | $3.06M | |
| 2023 | 148,189 | $3.22M | |
| 2024incomplete | 90,309 | $2.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 78,954 | 75,120 | $3.66M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.9% | 44,665 | 42,600 | $1.36M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.4% | 15,590 | 14,629 | $1.25M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.8% | 14,790 | 5,989 | $743K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.0% | 9,978 | 8,692 | $591K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.3% | 10,467 | 10,033 | $448K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.2% | 10,227 | 9,803 | $437K |
| 90961 | 2.2% | 3,107 | 3,104 | $433K | |
| 80053 | Comprehensive metabolic panel | 2.0% | 44,897 | 41,368 | $399K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.0% | 15,440 | 15,311 | $396K |
| 86481 | 1.9% | 4,224 | 4,206 | $375K | |
| 80061 | Lipid panel | 1.9% | 34,141 | 33,950 | $369K |
297 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 23,597 | $330K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 45,487 | $301K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.5% | 2,177 | $295K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.4% | 5,145 | $282K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.4% | 1,213 | $270K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 1.3% | 1,728 | $264K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 33,413 | $258K |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.2% | 2,150 | $244K |
| 86003 | 1.1% | 1,612 | $221K | |
| 59425 | 1.1% | 2,930 | $221K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.1% | 5,023 | $219K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.1% | 5,888 | $218K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 6,216 | $173K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 3,939 | $166K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,380 | $165K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 4,606 | $152K |
| 99223 | Prolong inpt eval add15 m | <1% | 1,782 | $151K |
| 90686 | <1% | 8,850 | $146K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,126 | $142K |
| 87480 | <1% | 5,883 | $137K | |
| 87510 | <1% | 5,804 | $136K | |
| 87660 | <1% | 5,710 | $133K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 813 | $128K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,135 | $122K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 5,370 | $117K |
| 95117 | <1% | 9,207 | $117K | |
| 86803 | <1% | 6,835 | $116K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 3,824 | $114K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 15,449 | $113K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,891 | $106K |
| 93000 | <1% | 9,460 | $106K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 17,080 | $101K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,850 | $99K |
| 82728 | <1% | 8,051 | $87K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 423 | $80K |
| 0002A | <1% | 1,953 | $76K | |
| 90837 | Psychotherapy session, about an hour | <1% | 846 | $75K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,392 | $75K |
| 91322 | <1% | 701 | $75K | |
| 0001A | <1% | 2,005 | $72K | |
| 84439 | <1% | 8,104 | $70K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,140 | $67K |
| 84153 | <1% | 4,082 | $64K | |
| 92134 | <1% | 3,691 | $62K | |
| 85027 | <1% | 12,181 | $61K | |
| 83970 | <1% | 3,016 | $55K | |
| 86480 | <1% | 775 | $53K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,260 | $53K |
| 82570 | <1% | 13,575 | $52K | |
| 83550 | <1% | 7,502 | $52K | |
| 87186 | <1% | 6,271 | $51K | |
| 81001 | <1% | 19,804 | $47K | |
| 83540 | <1% | 7,884 | $45K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 479 | $44K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 59 | $44K |
| 80076 | <1% | 6,544 | $43K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 837 | $43K |
| 86140 | <1% | 8,205 | $43K | |
| 0012A | <1% | 1,362 | $42K | |
| 87081 | <1% | 5,358 | $41K | |
| 87077 | <1% | 5,446 | $41K | |
| 0011A | <1% | 1,816 | $40K | |
| 87070 | <1% | 3,928 | $38K | |
| 82607 | <1% | 5,054 | $37K | |
| 90480 | <1% | 1,088 | $35K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 799 | $33K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 48 | $33K |
| 82043 | <1% | 8,795 | $33K | |
| 87340 | <1% | 2,728 | $33K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,679 | $29K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 165 | $28K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 307 | $27K |
| 86592 | <1% | 5,088 | $27K | |
| 93296 | <1% | 1,664 | $27K | |
| 83735 | <1% | 4,168 | $27K | |
| 82274 | <1% | 1,689 | $26K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 459 | $25K |
| 86765 | <1% | 1,740 | $25K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 336 | $25K |
| 82746 | <1% | 1,950 | $25K | |
| 86038 | <1% | 1,982 | $25K | |
| 80081 | <1% | 235 | $25K | |
| 86160 | <1% | 920 | $22K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 294 | $22K |
| 86706 | <1% | 1,641 | $22K | |
| 83690 | <1% | 3,170 | $21K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 475 | $20K |
| 83880 | <1% | 1,328 | $20K | |
| 83525 | <1% | 1,241 | $19K | |
| 85610 | <1% | 4,994 | $19K | |
| 99152 | <1% | 879 | $19K | |
| 82784 | <1% | 2,384 | $19K | |
| 82785 | <1% | 812 | $18K | |
| 93970 | <1% | 311 | $18K | |
| 91321 | <1% | 169 | $18K | |
| 82565 | <1% | 4,038 | $17K | |
| 84481 | <1% | 915 | $16K | |
| 84460 | <1% | 3,292 | $16K | |
| 99243 | <1% | 132 | $16K | |
| 85652 | <1% | 6,563 | $16K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 157 | $15K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 18 | $15K |
| 90656 | <1% | 792 | $15K | |
| 84156 | <1% | 4,726 | $15K | |
| 73630 | <1% | 646 | $15K | |
| 84100 | <1% | 3,068 | $14K | |
| 99000 | <1% | 2,903 | $14K | |
| 82670 | <1% | 410 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 407 | $14K |
| 83516 | <1% | 983 | $13K | |
| 92557 | <1% | 463 | $13K | |
| 90962 | <1% | 120 | $13K | |
| 92550 | <1% | 1,006 | $13K | |
| 99254 | <1% | 177 | $13K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 380 | $12K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 70 | $12K |
| 84550 | <1% | 3,626 | $11K | |
| 0064A | <1% | 284 | $11K | |
| 86762 | <1% | 623 | $11K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 162 | $10K |
| 0071A | <1% | 255 | $10K | |
| 0124A | <1% | 269 | $10K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 90 | $10K |
| 82947 | <1% | 2,659 | $10K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 516 | $9K |
| 82533 | <1% | 550 | $9K | |
| 87400 | <1% | 852 | $9K | |
| 84450 | <1% | 1,565 | $9K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 226 | $9K |
| 86735 | <1% | 535 | $9K | |
| 0072A | <1% | 213 | $8K | |
| 87045 | <1% | 748 | $8K | |
| 90662 | <1% | 770 | $8K | |
| 81003 | <1% | 4,050 | $8K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 63 | $8K |
| 99173 | <1% | 1,243 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 611 | $7K |
| 82550 | <1% | 1,497 | $7K | |
| 85651 | <1% | 1,718 | $7K | |
| 87147 | <1% | 971 | $7K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 98 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 211 | $7K |
| 83001 | <1% | 286 | $6K | |
| 93294 | <1% | 595 | $6K | |
| 87634 | <1% | 72 | $6K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 310 | $6K |
| 84165 | <1% | 964 | $6K | |
| 97139 | <1% | 294 | $6K | |
| 84403 | <1% | 322 | $6K | |
| 97810 | <1% | 244 | $6K | |
| 97811 | <1% | 242 | $6K | |
| 87205 | <1% | 1,468 | $6K | |
| 0134A | <1% | 170 | $6K | |
| 86376 | <1% | 331 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 55 | $6K |
| 93750 | <1% | 81 | $5K | |
| 93015 | <1% | 93 | $5K | |
| 93248 | <1% | 195 | $5K | |
| 86364 | <1% | 427 | $5K | |
| 80069 | <1% | 1,997 | $5K | |
| 99205 | Prolong outpt/office vis | <1% | 133 | $5K |
| 95115 | <1% | 505 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 113 | $5K |
| 87046 | <1% | 770 | $5K | |
| 93295 | <1% | 89 | $5K | |
| 85007 | <1% | 1,592 | $4K | |
| 84484 | <1% | 469 | $4K | |
| 86431 | <1% | 761 | $4K | |
| 80197 | <1% | 242 | $4K | |
| 86787 | <1% | 260 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 87 | $4K |
| 86258 | <1% | 336 | $4K | |
| 92551 | <1% | 421 | $4K | |
| 0004A | <1% | 100 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,087 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 44 | $4K |
| 83615 | <1% | 584 | $4K | |
| 87088 | <1% | 525 | $4K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 505 | $3K |
| 95144 | <1% | 26 | $3K | |
| 90694 | <1% | 535 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 426 | $3K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 26 | $3K |
| 73610 | <1% | 117 | $3K | |
| 92015 | Determination of refractive state | <1% | 275 | $3K |
| 94010 | <1% | 77 | $3K | |
| 93990 | <1% | 78 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 422 | $3K |
| 82951 | <1% | 152 | $3K | |
| 20610 | <1% | 188 | $2K | |
| 85730 | <1% | 306 | $2K | |
| 86665 | <1% | 65 | $2K | |
| 93246 | <1% | 158 | $2K | |
| 95813 | <1% | 41 | $2K | |
| 82105 | <1% | 141 | $2K | |
| 93351 | <1% | 20 | $2K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 13 | $2K |
| 92567 | <1% | 98 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 159 | $2K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 16 | $2K |
| 86704 | <1% | 135 | $2K | |
| 59025 | Fetal non-stress test | <1% | 55 | $2K |
| 82248 | <1% | 340 | $2K | |
| 90653 | <1% | 252 | $2K | |
| 76642 | <1% | 45 | $2K | |
| 81025 | <1% | 470 | $2K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 64 | $2K |
| 85018 | <1% | 738 | $2K | |
| 87329 | <1% | 160 | $2K | |
| 77014 | <1% | 32 | $2K | |
| 85379 | <1% | 163 | $2K | |
| 93971 | <1% | 84 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $2K |
| 84146 | <1% | 68 | $2K | |
| 83721 | <1% | 139 | $2K | |
| 64483 | <1% | 13 | $1K | |
| 64615 | <1% | 13 | $1K | |
| 86664 | <1% | 64 | $1K | |
| 0031A | <1% | 34 | $1K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 82 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 29 | $1K |
| 86663 | <1% | 64 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 61 | $1K |
| 76937 | <1% | 192 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 114 | $1K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 26 | $1K |
| 93793 | <1% | 193 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,336 | $962.64 |
| 86225 | <1% | 56 | $904.32 | |
| 93922 | <1% | 38 | $890.39 | |
| 93325 | <1% | 113 | $885.44 | |
| 51705 | <1% | 14 | $856.43 | |
| 73030 | <1% | 72 | $847.05 | |
| 82150 | <1% | 136 | $826.68 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 38 | $821.38 |
| 73564 | <1% | 44 | $792.87 | |
| 0112A | <1% | 18 | $720.00 | |
| 0054A | <1% | 23 | $710.00 | |
| 0074A | <1% | 17 | $680.00 | |
| 72100 | <1% | 26 | $671.21 | |
| 86769 | <1% | 12 | $670.85 | |
| 87420 | <1% | 156 | $656.43 | |
| 87075 | <1% | 76 | $644.98 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 44 | $636.21 |
| 92587 | <1% | 13 | $581.49 | |
| 84702 | <1% | 31 | $579.93 | |
| 86696 | <1% | 28 | $573.70 | |
| 0003A | <1% | 14 | $560.00 | |
| 20553 | <1% | 31 | $559.68 | |
| 83521 | <1% | 53 | $549.24 | |
| 31575 | <1% | 12 | $490.40 | |
| 87328 | <1% | 41 | $448.04 | |
| 92083 | <1% | 13 | $447.92 | |
| 84480 | <1% | 25 | $419.30 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 163 | $397.64 |
| 86308 | <1% | 51 | $390.68 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 133 | $383.56 |
| 86334 | <1% | 25 | $375.89 | |
| 96127 | <1% | 51 | $370.52 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $362.89 |
| 82627 | <1% | 12 | $349.37 | |
| 82977 | <1% | 38 | $332.59 | |
| 95251 | <1% | 13 | $330.21 | |
| 0296T | <1% | 24 | $327.61 | |
| 0298T | <1% | 36 | $312.32 | |
| 86200 | <1% | 38 | $302.70 | |
| 85045 | <1% | 107 | $300.98 | |
| 99429 | <1% | 12 | $300.00 | |
| 92579 | <1% | 13 | $292.44 | |
| 90670 | <1% | 15 | $270.00 | |
| 81015 | <1% | 88 | $247.90 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 70 | $226.28 |
| 82950 | <1% | 38 | $222.45 | |
| 86695 | <1% | 13 | $214.15 | |
| 94060 | <1% | 12 | $213.12 | |
| 84132 | <1% | 156 | $207.26 | |
| 92133 | <1% | 12 | $199.16 | |
| 93298 | <1% | 12 | $196.12 | |
| 99307 | <1% | 72 | $191.64 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 38 | $190.78 |
| 77080 | <1% | 29 | $186.77 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $151.55 |
| 87493 | <1% | 12 | $143.27 | |
| 83655 | <1% | 30 | $135.04 | |
| 87324 | <1% | 12 | $113.05 | |
| 87206 | <1% | 14 | $103.86 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 53 | $96.35 |
| 97014 | <1% | 27 | $69.53 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 45 | $61.61 |
| 82330 | <1% | 28 | $60.84 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 28 | $36.12 |
| 90785 | <1% | 43 | $3.88 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 13 | $0.74 |
| G0008 | Administration of influenza virus vaccine | 0% | 797 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 52 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 50 | $0.00 |
| 93307 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOPES, KRISTA (SH VP, QUALITY, SAFETY, PATIENT EDU)
| Provider | Location | Paid |
|---|---|---|
| Sutter Valley Medical Foundation | Sacramento, CA | $41.25M |
| Sutter Bay Medical Foundation | Sacramento, CA | $18.88M |
| Sutter Valley Medical Foundation | Modesto, CA | $18.22M |
| Sutter Valley Medical Foundation | Yuba City, CA | $12.47M |
| Sutter Bay Medical Foundation | Orinda, CA | $6.77M |
| Sutter Valley Medical Foundation | Fairfield, CA | $3.92M |
| Sutter Valley Medical Foundation | Sacramento, CA | $3.85M |
| Sutter Valley Medical Foundation | Yuba City, CA | $2.45M |
| Sutter Valley Medical Foundation | Brownsville, CA | $1.37M |
| Sutter Valley Medical Foundation | Plymouth, CA | $407K |
| Sutter Valley Medical Foundation | Modesto, CA | $303K |
| Sutter Valley Medical Foundation | Yuba City, CA | $272K |
| Sutter Valley Medical Foundation | Yuba City, CA | $93K |
| Sutter Bay Medical Foundation | Santa Cruz, CA | $77K |
| Sutter Medical Foundation | Yuba City, CA | $31K |
| Sutter Bay Medical Foundation | Palo Alto, CA | $29K |
| Sutter Bay Medical Foundation | Mountain View, CA | $22K |
| Sutter Bay Medical Foundation | Palo Alto, CA | $11K |
| Sutter Bay Medical Foundation | Los Gatos, CA | $10K |
| Sutter Bay Medical Foundation | Palo Alto, CA | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.